|
C21ORF45 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.319800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.097560E-01 |
| Normal-vs-Stage2 |
4.537700E-02 |
| Normal-vs-Stage3 |
1.308590E-01 |
| Normal-vs-Stage4 |
8.238000E-01 |
| Stage1-vs-Stage2 |
4.411200E-01 |
| Stage1-vs-Stage3 |
5.737000E-03 |
| Stage1-vs-Stage4 |
5.919400E-01 |
| Stage2-vs-Stage3 |
7.759700E-03 |
| Stage2-vs-Stage4 |
2.499000E-01 |
| Stage3-vs-Stage4 |
2.793200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.082200E-01 |
| Normal-vs-AfricanAmerican |
5.813000E-01 |
| Normal-vs-Asian |
4.706000E-01 |
| Caucasian-vs-AfricanAmerican |
7.770800E-01 |
| Caucasian-vs-Asian |
3.761200E-01 |
| AfricanAmerican-vs-Asian |
4.076400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.068440E-01 |
| Normal-vs-Female |
2.634600E-01 |
| Male-vs-Female |
1.091690E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.180800E-01 |
| Normal-vs-Extreme_Weight |
6.438400E-02 |
| Normal-vs-Obese |
6.538400E-01 |
| Normal-vs-Extreme_Obese |
4.653600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.327400E-01 |
| Normal_Weight-vs-Obese |
2.700200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.720600E-01 |
| Extreme_Weight-vs-Obese |
3.780300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.355000E-01 |
| Obese-vs-Extreme_Obese |
1.157190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.260400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.003800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.732400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.310400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.386190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.173420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.348350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.227200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.486200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.840200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.188010E-01 |
| Normal-VS-Type2 PRCC |
5.819200E-01 |
| Normal-VS-KIRP CIMP |
4.235700E-04 |
| Normal-VS-Unclassified PRCC |
3.814600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.935800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.751800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.324600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.476800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.912000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.261800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.771500E-02 |
| Normal-vs-N1 |
1.506110E-02 |
| Normal-vs-N2 |
6.579600E-01 |
| N0-vs-N1 |
1.718310E-03 |
| N0-vs-N2 |
9.915400E-01 |
| N1-vs-N2 |
1.567780E-01 |
|
|
